24 results
8-K
EX-99.1
ACHV
Achieve Life Sciences Inc.
14 Aug 23
Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update
4:06pm
demographics, including age, gender, race, and prior smoking history. Cytisinicline was well-tolerated, with no reports of serious adverse events
8-K
EX-99.1
mwmq9g6
9 May 23
Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update
4:13pm
8-K
EX-99.1
z43mr v2xbk9az
11 Jun 19
Achieve Life Sciences Announces Statistically Significant
7:16am
425
EX-10.1
y91hh
5 Jan 17
Business combination disclosure
12:00am
425
EX-10.2
f1tdpm0grbcgwy0 i1
5 Jan 17
Business combination disclosure
12:00am
425
EX-2.1
wloikj
5 Jan 17
Business combination disclosure
12:00am
8-K
EX-99.2
er3uec8o8
11 Mar 09
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
12:00am
DEFM14A
k315odb4fogt 2ak
3 Jul 08
Proxy related to merger
12:00am